| Literature DB >> 32638391 |
Michiel J Bakkum1,2, Jelle Tichelaar1,2,3, Paraskevi Papaioannidou3,4, Robert Likic3,5, Emilio J Sanz Alvarez3,6, Thierry Christiaens3,7, João N Costa3,8, Romaldas Mačiulaitis3,9, Lorena Dima3,10, Jamie Coleman3,11, Milan C Richir1,2, Michiel A van Agtmael1,2,3.
Abstract
AIM: Improvement and harmonization of European clinical pharmacology and therapeutics (CPT) education is urgently required. Because digital educational resources can be easily shared, adapted to local situations and re-used widely across a variety of educational systems, they may be ideally suited for this purpose.Entities:
Keywords: Prescribing; clinical pharmacology and therapeutics; digital; education; open educational resources
Mesh:
Year: 2020 PMID: 32638391 PMCID: PMC9328439 DOI: 10.1111/bcp.14453
Source DB: PubMed Journal: Br J Clin Pharmacol ISSN: 0306-5251 Impact factor: 3.716
Overview of resource characteristics
| Type of resource | Frequency | Median time to complete | Available on‐demand | Blended | Case‐based | Compulsory |
|---|---|---|---|---|---|---|
| E‐learning | 21 (23.9%) | 90–120 min. | 14 (66.7%) | 13 (61.9%) | 7 (33.3%) | 7 (33.3%) |
| PK/PD simulator | 9 (10.2%) | 40–60 min. | 2 (22.2%) | 8 (88.9%) | 2 (22.2%) | 4 (44.4%) |
| Video | 8 (9.1%) | 20–60 min. | 5 (62.5%) | 6 (75.0%) | 2 (25.0%) | 0 (0%) |
| Digital assessment | 7 (8.0%) | 60–90 min. | 1 (14.3%) | 1 (14.3%) | 3 (42.9%) | 4 (57.1%) |
| Virtual patient | 7 (8.0%) | 60–90 min. | 3 (42.9%) | 5 (71.4%) | 7 (100%) | 2 (28.6%) |
| CDSS | 7 (8.0%) | 20–40 min. | 4 (57.1%) | 3 (42.9%) | 0 (0%) | 2 (28.6%) |
| Student formulary | 4 (4.5%) | > 120 min. | 4 (100%) | 3 (75%) | 2 (50%) | 2 (50%) |
| Digital book | 5 (5.7%) | 90–120 min. | 3 (60%) | 3 (60%) | 2 (40%) | 0 (0%) |
| (In‐class) social media | 5 (5.7%) | 0–20 min. | 3 (60%) | 3 (60%) | 3 (60%) | 1 (20%) |
| Serious game | 4 (4.5%) | 20–40 min. | 2 (50%) | 2 (50%) | 0 (0%) | 0 (0%) |
| Slide repository | 3 (3.4%) | 20–40 min. | 2 (66.7%) | 0 (0%) | 1 (33.3%) | 1 (33%) |
| Audio | 2 (2.3%) | 20–40 min. | 1 (50%) | 0 (0%) | 1 (50%) | 0 (0%) |
| Recorded lectures | 2 (2.3%) | > 120 min. | 2 (100%) | 1 (50%) | 1 (50%) | 1 (50%) |
| EPS sandbox | 2 (2.3%) | 90–120 min. | 1 (50%) | 0 (0%) | 1 (50%) | 0 (0%) |
| Augmented reality | 1 (1.1%) | 90–120 min. | 1 (100%) | 1 (100%) | 1 (100%) | 0 (0%) |
| Faculty website | 1 (1.1%) | 40–60 min. | 1 (100%) | 1 (100%) | 0 (0%) | 0 (0%) |
|
|
|
|
|
|
|
|
Blended means combined with in‐class teaching on the same subject. PK, pharmacokinetics; PD, pharmacodynamics; CDSS, clinical decision support system; EPS, electronic prescribing system.
Definitions used for the classification of resources
| Resource type | Definition used for this study |
|---|---|
| E‐learning | Computer‐based course that offers a variety of texts, multimedia and interactive elements. Often, though not necessarily, online. |
| PK/PD simulator | Interactive visualization of pharmacokinetics and/or pharmacodynamics modelling. |
| Video | Educational video (other than recorded lecture). |
| Digital assessment | Formative or summative examination using computer technology. |
| Virtual patient | Interactive patient scenario (may be text‐based or high‐fidelity software simulations, not mannequins or real‐life actors). |
| Knowledge databases and computerized clinical decision support systems | Database with drug information or clinical practice guidelines, drug–drug interaction checker or other computerized clinical decision support. |
| Student formulary | A digital drug formulary created by students (as personal or collaborative effort), used for educational purposes. |
| Digital book | Digitized books, primarily text‐based but may contain interactive elements and multimedia. |
| (In‐class) social media | Software applications that enable students to interact with peers and/or teachers. |
| Serious game | Game designed to educate its users (may be text‐based or high‐fidelity simulation, not non‐digital games). |
| Slide repository | A digital archive of slides or images used for educational purposes. |
| Audio | Educational audio files (other than recorded lecture). |
| Recorded lectures | Recordings of lectures to be replayed at a later time. May be audio files, screen captures or a combination of both. |
| EPS sandbox | A copy of the electronic health records and/or prescribing system, created for educational purposes. May contain fictional or anonymized patients. |
| Augmented reality | Computer‐generated images projected on a real‐world view. |
E‐learning is also commonly used as synonym for all types of digital educational resources. Please note that for this study, the more‐strict definition was used in order to distinguish computer‐based courses from other types of digital education.
FIGURE 1Use of digital educational resources in the European Union
Learning objectives
| Learning objectives | No. of resources | Learning objectives | No. of resources |
|---|---|---|---|
|
|
| ||
| 1. Introduction to clinical pharmacology and therapeutics | 5 | 13. Legal and ethical aspects of prescribing | 3 |
|
|
|
|
|
|
|
|
|
|
| 2. Pharmacodynamics | 17 | 14. Prescribing for patients with special requirements | 16 |
|
|
|
|
|
|
|
|
|
|
| 3. Pharmacokinetics | 23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 4. Individual variability in the response to drugs | 13 | 15. Rational prescribing | 18 |
|
|
|
|
|
|
|
|
|
|
|
|
| 16. Clinical toxicology | 2 |
| 5. Adherence, compliance, and concordance | 4 | 17. Misuse of drugs | 3 |
|
|
| 18. Complementary and alternative medicine | 2 |
|
|
| 19. Use of antibiotics and antibiotic resistance | 15 |
| 6. Therapeutic drug monitoring | 2 | 20. Commonly used and high‐risk medicines | 34 |
|
|
| ||
|
|
|
| |
| 7. Adverse drug reactions | 21 | 21. Medication history taking | 4 |
|
|
| 22. Rational prescribing | 20 |
|
|
| 23. Drug dose calculation | 11 |
|
|
| 24. Prescription writing | 12 |
|
|
| 25. Non‐drug therapy | 2 |
| 8. Drug interactions and contraindications | 18 | 26. Communication | 6 |
|
|
| 27. Reviewing prescriptions | 4 |
|
|
| 28. Adverse drug reactions | 7 |
| 9. Medication errors | 10 | 29. Clinical toxicology | 0 |
| 10. Drug discovery, development, and regulation | 6 | 30. Obtaining information from guidelines and protocols to support prescribing | 14 |
|
|
| 31. Monitoring medication | 8 |
|
|
| ||
| 11. Medicines management | 5 |
| |
|
|
| 32. Risk–benefit analysis | 8 |
|
|
| 33. Recognizing personal limitations and knowledge | 1 |
| 12. Evidence‐based prescribing | 18 | 34. Balanced approach to the introduction of new drugs | 4 |
|
|
| ||
|
|
| ||
|
|
|
Sub‐objectives are shown in italic. When a resource addressed more than one sub‐objective, the main objective was only counted once. Learning objectives were previously defined in Brinkman et al.